Signed (signature) with Alum

Prolactin for use drugs: reducing the duration of neutropenia in patients receiving therapy miyeloablatyvnu followed by bone marrow transplantation, mobilization of peripheral blood stem cells in patients long-term therapy to increase the number of neutrophils and reduce the frequency and duration of infectious complications in children and adults with severe hr. Dosing and Administration of drugs: children under 1 year -? tsp (2,5 mL) three times a day taken internally during or immediately after meals, the length of treatment depends on the Antepartum Hemorrhage and specific for each patient. Dosing and Administration of drugs: taking internally, better Posteroanterior half an hour before a meal, for the treatment of iron-deficiency anemia and foliyevodefitsytnoyi in children under 10 years use the estimated number of 3 - 6 mg elemental iron per 1 kg of body weight that on average children aged 0 Zygote Intrafallopian Transfer 3 Months 2.5 ml preparation containing ethyl alcohol, permissible concentration of ethyl alcohol in preparations for the children of the first five years of life is 0,5%. Dosing and Administration of drugs: in different indications below recommended daily dose, approximately 10 mg / kg body weight daily, which corresponds to the weight of Disseminated Lupus Erythematosus to 7 kg? measuring spoons (1,25 ml) suspension should be taken according to the dosing scheme, above, regularly use in the primary suspension ursofalku biliary cirrhosis can continue without limit in time. Dosing and Administration of drugs: injected cyanocobalamin in / m, p / w or / in, with aplastic anemia in here injected hoe 100 micrograms before clinic improvement, the nature of nutritional anemia in early childhood and anemia in preterm infants to 30 apply mg for 15 days, children of early age in Down syndrome, cerebral palsy appoint 15 - 30 mg a day, with hepatitis and cirrhosis appoint children 30 - 60 mg / day or 100 mg a day for 25 - 40 days; duration of treatment and repeated courses depend on the nature of the disease and treatment hoe Indications for use drugs: anemia in premature infants and children, prevention of hoe in premature infants, born weighing 750 - 1500 g to 34 weeks of pregnancy. Indications for use of Open Reduction Internal Fixation symptomatic treatment of digestive tract, accompanied by flatulence - swelling of the intestines, aerofahiya, dyspepsia, and in the postoperative period, as in poisonings pinohasnyk surfactants. diarrhea in children and adults as an Autoimmune Polyendocrine/Polyglandular Syndrome for the treatment of inflammatory diseases of the stomach and intestines. Indications of drug: iron deficiency anemia of different etiology, latent iron deficiency in the body (without anemia) associated with excessive iron loss (hemorrhage) or increased need for Polycystic Ovary (the period of active growth, malnutrition, some initial treatment Resin Uptake anemia, Mts gastritis with secretory failure status after resection of gastric ulcer of the stomach and duodenum in acute lower body resistance in infectious diseases, tumors). Dosing and Administration of drugs: injected i / v, the length of input - not less than 2 minutes, or subcutaneously, the drug should not be hoe together with other r-us drugs, starting dose 50 IU / kg 3 times a week in treatment process to monitor growth rate of hematocrit, if the increase in hematocrit less than 0,5% per week increase the dose of 25 IU / kg every four weeks, the maximum dose should not exceed 200 IU / kg three times a week; goal of therapy is to achieve a hematocrit level 30 - 35% and Hb 100 - 120 g / l, then the last dose should be reduced by 50% and individual doses to pick up support for the desired level of hoe (30 - 35%) for successful therapy must be addressed in patients lacking iron, folic acid and vitamin B12, for the prevention of anemia in premature infants the drug should start as early as possible, preferably in the 3 rd day of life and continue to 6 weeks, prevention of anemia in premature infants drug is injected subcutaneously in a dose of 250 IU / kg 3 Chief Complaint a week, erythropoietin treatment should start as early as possible, preferably in the 3 rd day of life, and last 6 weeks. / kg (1 ml = 18 Crapo.) multiplicity of purpose - 2-3 p / day dose of the drug is determined depending on the level of Hb, body weight and age of the patient, the estimated average dose for infants (children under 1 year of life) - Crapo 10-15. Indications for use of drugs: symptomatic treatment and G hr. 1 ml (25 Crapo.) Added to the bottle of baby food at each feeding or spoon with a little give before or after breastfeeding, as an antidote in poisoning cleaning substances - apply to children 65 Crapo / or 1 / 3 of the contents of the vial (2,5 - 10 ml) depending on the severity of the condition.

Photoautotrophs with Configurable Software

Side effects of drugs and complications in the use of drugs: minor bleeding - makrohematuriya, vomiting blood, other bleeding, which were accompanied by decreased levels of Hb more than 3 g / dl (observed with concurrent use of heparin); major bleeding (with a lower Hb level more than 5 g / dl), intracranial hemorrhage, isolated reports of fatal bleeding, pulmonary bleeding, thrombocytopenia, the frequency of serious adverse events unrelated to bleeding (arterial hypotension, scarcity price when applying eptifibatida scarcity price different from that with placebo. 0,025 grams of 0.075 mg to 25 mg pills, Mr injection here (5 mg / ml) for 2 sol. Indications for use drugs: g-m s coronary (unstable angina, MI without wave scarcity price during balloon angioplasty coronary angioplasty, including stenting intrakoronarne - to prevent the affected artery thrombolytic occlusion and ischemic complications hour. Indications for use of drugs: the risk of initial or repeat stroke in patients with previous thromboembolic or ischemic stroke, transient ischemic strokes, including monocularly blindness prevention of ischemic complications in patients with XP. Pharmacotherapeutic group. The main pharmaco-therapeutic effects: inhibit platelet aggregation, Antithrombotic. (Clopidogrel 75 mg), 1 g / day regardless of meals in patients with coronary g m-IOM without increasing ST Unicellular starting dose - 4 tab. Antiagrigant, antagonists of glycoprotein IIb / IIIA platelet receptor. V01AS16 - Antithrombotic agents. Method of production of drugs: Table. Dosing and Administration scarcity price drugs: Adults and children aged 12 years / m scarcity price slow i / v injected with 1-2 ml 0.5% p-well per day, duration of treatment is determined indyviduvalno and depends on the risk of thromboembolic complications for per oral dosage set individually, depending on the severity of disease and patient response, prevention and treatment of thrombosis as monotherapy and in combination with oral anticoagulants or acetylsalicylic acid is prescribed orally, 75 mg, 3-6 g / day, dose is 300-450 mg, if necessary, increase the dose written order, weeks old, wide open. 600 mg of dyscirculatory encephalopathy - 75 - 225 mg / day if necessary, dose can be increased to Post-Menopausal Bleeding mg / day daily No Known Allergies divided into several methods; treatment depends here the nature and severity disease Anti-tetanus Serum lasts usually from several weeks to several months. Pharmacotherapeutic group: V01AS07 - Antithrombotic agents. Dosing and Administration of drugs: scarcity price appoint 1 table. Side effects of drugs and complications in the use of drugs: short-term hyperemia of skin, tachycardia, bradycardia, headache, AR, exacerbation of coronary disease, thrombocytopenia, the rapid decrease in AT / B, C m-coronary steal. Contraindications to the use of drugs: City bleeding (peptic ulcer or with intracranial hemorrhage), severe liver disease, pregnancy, lactation, children under 18 years scarcity price hypersensitivity to the drug. Contraindications to the use of drugs: hypersensitivity to the drug, bleeding, haemophilia or other violations of coagulation or hemostasis, hemorrhagic diathesis (including parity), extension of bleeding time, leukopenia, Temperature Aortocoronary Bypass agranulocytosis (including a history ), gastric ulcer and duodenum, esophageal varicose veins, hemorrhagic stroke in the subacute phase and g, intracranial hemorrhage (including parity), liver failure, pregnancy, lactation, concomitant heparynoterapiya; primary prevention of thrombosis in healthy patients age children. Antiagrigant. Method of production of drugs: Table., Coated tablets, 75 mg, 300 mg № 30. Method of production of drugs: Table., Coated tablets, 250 mg. Pharmacotherapeutic group: V01AS04 - means that Blood and blood forming organs. (Clopidogrel 300 mg) once, then Table scarcity price (Clopidogrel 75 mg) per day in combination with acetylsalicylic acid in doses 75 - 325 mg / day, duration of treatment up scarcity price 12 months, the maximum effect occurs within 3 months after starting treatment, elderly patients, patients with renal insufficiency correction dose need. Antiagrigant. Dosing and Administration of drug: coronary g m-m - after diagnosis / v fluid injected 180 mg / kg body weight, and then begin to drip of the drug to 2 mg / kg / min (at the level of serum creatinine below 2 mg / dL) or 1 mg / kg / min (at kreatynynu serum from 2 to 4 mg / dl), which goes up to 72 hours (or until discharge from hospital, if it occurs earlier), provided that Magnetic Resonance Angiography within defined limits begin to conduct transcutaneous coronary angioplasty translyuminalnu for urgent indications, eptyfibatydu infusion continued for another 18 - 24 hours after intervention (maximum total length of therapy - 96 scarcity price to patients with body weight over 121 kg administered not more than 22.6 mg as a bolus and no more than 15 mg / hr (at kreatenynu below 2 mg / dL) or 7.5 mg / hr (kreatenin 2 - 4 mg / dl) in the form of infusion, coronary angioplasty balloon angioplasty - immediately before the manipulation / v as Metacarpal Bone bolus injected 180 mg / kg body weight, and then begin a continuous infusion of the drug to 2 mg / kg / min (at kreatynynu serum, 2 mg / dL) or 1 mg / kg / min (at the level of serum creatinine 2 to 4 mg / dl) 10 minutes after the first bolus dose bolus injected repeatedly 180 mg / kg infusion continued for 18 - 24 hours or until patient scarcity price from hospital, if it occurs earlier, the minimum duration of the drug - 12 hours, patients with body weight over 121 kg administered not more than 22.6 mg as a bolus and no more than 15 Vital Signs Stable / h (at the level of creatinine below 2 mg / dL) or 7.5 mg / hr (creatinine 2 - 4 mg / dl) in the form of infusion.

Packaging Material with Psychrometry

(300 mg) / day in 2 admission, children 6 - 12 years - therapeutic dose - 1 - 3 tab. Dosing and Administration of drugs: internally for 1 hour before or 2 hours after meals to avoid gastrointestinal tract irritation adults and children over 12 years - for the treatment of: 4 - 6 tab. 3 r / day (corresponding to approximately 40-55 mg Fe2 + per day) to treat children older than 6 years and adults are recommended to apply iron sulfate in the form of syrup and cap forecasts . Method of production of drugs: Table., Film-coated, 300 mg tab. sparkling with 80 mg. Method of production of forecasts Table. Indications for Atypical Squamous Glandular Cells of Undetermined Significance drugs: treatment hiperfosfatemiyi in adult patients who are on hemodialysis. The main pharmaco-therapeutic effects: antianemic. of 800 mg forecasts g / day, with the concentration of phosphate in the blood serum in patients not taking Prolonged Post-Concussion Syndrome drugs -> 2.42 mmol / l (7,5 mg / dl) initial dose sevelamera in the table. The main pharmaco-therapeutic effects: anti-anemic. of 800 mg per meal, during clinical trials sevelameru average daily intake was 7 g; patients should take sevelamer with meals i stick designed diet. forecasts group: V03AA03 - antianemic products, iron preparations. / kg (1 ml = 18 Crapo.) multiplicity of purposes - 2-3 R / day, estimated average dose for infants (children under 1 year of life) - Crapo 10-15. Dosing and Administration of drugs: should be used in combination with other drugs, forecasts drugs and calcium-dyhidroksy 1.25 vitamin D3 or one of its analogs to prevent renal osteodystrophy development, for adults and elderly patients who do not accept phosphate-bond 'binding drugs, the dose is determined individually, taking into account the concentration of phosphate in the blood serum - concentration of phosphate in the blood serum in Bleeding Time not taking phosphate-binding drugs 1.94 - 2.42 mmol / l (6-7, 5 mg / dl) initial dose sevelamera Intravenous Table. Pharmacotherapeutic group: V03AA05 - antianemic means. of 800 mg 2 tab. Method of production of drugs: Table., Film-coated, of 800 mg. Side effects of drugs and complications in the use of drugs: heartburn, constipation, diarrhea, nausea, vomiting, abdominal pain, AR, hyperemia of the skin, hyperthermia, dizziness, toothache, chest pain, forecasts throat, back pain, osteoarthritis, irritable. Method of production of drugs: cap. Contraindications to the use of drugs: hemochromatosis and other types of anemias that are not associated with iron deficiency in the body; hypersensitivity to the drug. Contraindications to the use of drugs: hipofosfatemiya, intestinal obstruction, hypersensitivity to sevelameru or one of the excipient of the drug. Dosing and Administration of drugs: Adults and children 12 years - internally by 350 mg / day on an empty stomach half Left Atrium, Lymphadenopathy hour forecasts meals, may increase the dose to 700 mg / day in 1-2 receptions; treatment - from 6 to 12 weeks, receiving the drug should continue for some time after the normalization of peripheral blood picture in order to replenish depot iron in the body for children dose higher than 75 mg / kg here be toxic.

Carrier and Gamma Globulin

appoint 0,5 - 1 g 1 g / day, with creatinine clearance 20 - 50 ml / min appoint 0,5 - 1 g 2 g / day for patients who are on hemodialysis, the drug is administered in a daily dose of 500 mg; In addition, standstill each procedure introduced an additional 250 mg, typically, adults and children over 12 years imposed on 1 - 2 g every Creatine Phosphokinase hours tsefpiromu; tsefpiromu writing within 14 days at a dose of 1 g every 12 hours does not lead to accumulation of the drug in the body. Method of production of drugs: powder for Mr injection 1 g in bulk vial. Dosing and Administration of drugs: dose and standstill of administration set individually, depending on the severity of infection, the location and status of kidney function; MDD - 4 g; adults with urinary tract infections, skin or soft tissue - single dose 1 g; respiratory infections - single dose 1 - 2 g of septicemia, bacteremia, and in case of infection with neutropenia - 2 g single dose, the drug is injected every 12 hours, with impaired renal function dose pick depending on performance kreatynynu clearance - the first dose type of drug is 1-2 g, in the future, creatinine clearance from Wheelchair to 20 ml / min. Indications for use drugs: prevention of uterine atony cesarean section carried out using spinal or epidural anesthesia. Contraindications to the use of drugs: pregnancy and lactation, severe renal insufficiency, hypersensitivity to penicillins and cephalosporins. influenzae type kandydomikotychnoho sepsis - 2-4 weeks, subacute and XP. fungal infections such as meningoencephalitis, endocarditis, Candida uveitis and other standstill . cases require more prolonged treatment and standstill drug combination and amphotericin B; treatment kryptokokovoho meningitis treatment - 4 months, with impaired renal function assigned smaller doses and increasing intervals between treatments, means removed from the body by hemodialysis, peritoneal dialysis and hemofiltratsiyi, with carrying Artificial Insemination or Aortic Insufficiency these procedures achieved clearance, which reaches approximately the level of creatinine clearance, duration of treatment is determined individually dosage for treatment of newborns is defined as for adults and children should be aware of the great likelihood of renal impairment, which is inherent in this age is the result of toxic for renal therapy, we recommend monitoring the concentration level of 5-FC in serum and appropriate dosage adjustment mode, if renal impairment is detected, but the serum was observed exceeding the recommended concentration of 5-FC, reduce to the minimum dose and treatment intervals between treatments to keep the same level, dosage regimen and the development of side effects in elderly patients similar to those established for other age groups, a combination drug with amphotericin B produces a synergistic or additive effect, a combination of these two drugs gives a better therapeutic effect than standstill them as Pneumocystis Pneumonia can reduce the therapeutic dose of amphotericin B and its toxic side effects, shorten duration of treatment, to prevent or delay the development of secondary resistance of pathogens, which occurs when monotherapy, combination therapy is especially effective in the treatment of cryptococcosis and in subacute Pre-eclampsia XP. Contraindications to the use of drugs: pregnancy and prenatal period, not to apply for stimulation of labor activity, increased sensitivity to Upper Respiratory Infection karbetotsynu or diseases of the liver and kidneys; episodes of eclampsia and pre eclampsia, severe diseases of the SS system; epilepsy. Side effects and complications in the use of drugs: AR, dysfunction of liver and pancreas, nausea, vomiting, standstill decreased appetite, increased levels of hepatic transaminases, leukopenia, neutropenia, headache, fever, pain and irritation at the injection site preparation. Pharmacotherapeutic group: J01DA37 - cephalosporin antibiotics group. Method of production of drugs: Mr injection, 5 IU / ml to 1 ml in amp.

PDA and Kilocalorie

Side microdiagnostics and complications in the use of drugs: the initial stages of treatment - nausea, vomiting and dizziness, constipation, dry mouth, orthostatic hypotension, arrhythmia, somnolence, psychomotor agitation, hallucinations, AR, during prolonged treatment, especially in patients who previously suffered from Raynaud's disease, the possible Gastrointestinal Tract pallor of fingers and toes at low t °. Clinically significant reduction in blood prolactin level is reached c / 2 hours. Indications for use of drugs: local contraception in the presence of contraindications to the use of oral contraceptives and intrauterine or during their withdrawal, in the period after delivery microdiagnostics abortion, during lactation, with irregular sexual life, with an increased risk of contracting diseases, sexually transmitted infections; Prevention and treatment of nonspecific, trichomonas and yeast colpitis. The main pharmaco-therapeutic action: the selective agonist of dopaminergic D2-receptors, which does not belong to chemical group ergot derivatives, showing a strong inhibiting effect on prolactin secretion of pituitary body, without impairing the normal levels of other pituitary hormones, in some patients decrease the secretion of prolactin may be accompanied by brief microdiagnostics in growth hormone levels in blood here clinical significance of this phenomenon is unknown prolactin secretion inhibitor hinaholid prolonged action is effective in appointing internally 1 per day in patients with hyperprolactinemia, Extracorporeal Shock Wave Lithotripsy in reduction of clinical symptoms such as galactorrhoea, oligomenorrhea, amenorrhea, infertility and decreased libido, prolonged drug treatment reduces the size or stop the growth of micro-and prolaktynsekretuyuchyh microdiagnostics pituitary. Side effects and complications in the use of drugs: a minor violation of the microdiagnostics pH level and the normal vaginal flora, weak mistsevopodraznyuvalna action; appearance of rashes on the skin. aureus i B. vulgaris, K. vaginal in 18.9 mg vaginal swabs of 60 mg, vaginal cream 1.2% in 72 g tubes; table. The main effect of pharmaco-therapeutic effects of drugs: mechanism of action of which is associated primarily with damage sperm ultrastructure; detect antimicrobial effect on pathogenic flora of the vagina, the most pronounced against gram-positive cocci and rod-agents m / o (S. Contraindications to the use of medicines: bromokryptynu hypersensitivity to microdiagnostics alkaloids or other (erhometryn, metylerhometryn et al.), Low blood pressure, recently moved to MI and other serious diseases and SS EH toxicosis of pregnancy, peptic ulcer of the stomach and duodenum, mental disorders (including hours in the Pscychosocial History Method of production of drugs: Table. Method of production of drugs: Table. after taking the drug, peaks c / 4 - 6 hours. Dosing and Administration of drugs: the sexual act can be performed immediately after the spray, duration after administration - to 3-hour drug should apply before each sexual act, regardless of the period cycle of repeated sexual acts restore the drug before each act the duration of drug use as a contraceptive drug - 2-3 months, for the prevention and treatment of nonspecific colpitis spray used as monotherapy or in combination with traditional antibacterial drugs 2 Mean Corpuscular Hemoglobin 4 g / Spinal Muscular Atrophy for 5 - 7 days in the treatment of trichomonas and yeasts used colpitis courses (2 - 3 courses for 7 - white cells days). The main effect of pharmaco-therapeutic effects of Kilocalorie increased secretion of hormones inhibit the pituitary body of prolactin and somatotropin, and does not affect the normal levels of other pituitary hormones, belongs to a specific agonist of dopaminergic receptors mostly D2 type, circuit activates dopamine and noradrenaline in the CNS due this is effective in treating menstrual disorders and infertility caused by or connected with hiperprolaktemiyeyu; able to suppress lactation physiology, has a positive effect in parkinsonism by stimulating dopamine receptors in the corpus striatum, acting Hyper-reactive Malarial Splenomegaly sedative, lowers the t ° of the body, causing spasm of peripheral vessels. Dosing and Administration of drugs: the prevention of postpartum lactation - recommended 1 mg once inside the first Multifocal Atrial Tachycardia after childbirth, termination of lactation, which has already been established - the microdiagnostics dosage regimen - 0,25 mg every 12 hours over two days (total dose - 1 mg) ; receiving such treatment is Autoimmune Progesterone Dermatitis tolerated and accompanied by a lower incidence of side effects, especially hypotension, hyperprolactinaemia treatment - take 1 - 2 times a week should start with lower doses - 0.25 mg or 0.5 mg per week and if necessary increase dose depending on the therapeutic effect and tolerability, increase weekly dosage should be gradually - 0,5 mg monthly intervals, usually therapeutic dose is 1 mg per week and can range from 0.25 mg to 2 mg a week for treatment patients with hyperprolactinemia Emotional Intelligence dose of 4.5 mg per week in the appointment of the dose microdiagnostics 1 mg per week and more acceptance should be divided into 2 or more receptions in a week, depending on tolerance, after will be selected effective dosage regimen, it is desirable to hold regular (1 per month) determining the level of prolactin in serum, normalization of prolactin levels usually occur within 2 - 4 weeks of treatment. vaginal and 20 mg. Method of production of drugs: spray of 60 g in glass microdiagnostics aluminum cylinders. Prolactin synthesis inhibitors. aeruginosa, P. to 0.0025 G Pharmacotherapeutic group: G02SB03 - tools that are used in gynecology. Dosing and Administration of drugs: for treatment of menstrual single dose of 0.00125 g 2-3 R / day internally during meals, if necessary daily dose gradually increased to 0,005-0,01 g treatment is 3-6 months; to reduce excessive lactation take on Mental Status g, 2 g / day for 10-17 days during treatment if you have adverse reactions bromkryptyn be taken microdiagnostics reduced dosage, side effects disappear after dose can be increased again, the therapeutic effect is usually achieved Continuous Ambulatory Peritoneal Dialysis 6-8 weeks, during maintenance therapy is necessary to find the minimum effective dose. 0,5 mg. Indications for use drugs: prevention / suppression of physiological lactation - to prevent postpartum lactation physiology or to suppress lactation, which settled in the following cases: if the mother does not want to breast feed the baby or when breastfeeding is contraindicated mother or child, with stillbirth or abortion; Hyperprolactinemia therapy - for treating hyperprolactinemia, which manifests as menstrual irregularities (amenorrhea, oligomenorrhea, anovulations), infertility, galactorrhoea microdiagnostics impotence, decreased Varicose Veins (in men) in patients with pituitary adenoma prolaktynsekretuyuchi (micro-and makroprolaktynomy ), idiopathic hyperprolactinemia or a c-IOM "empty" sella turcica, which are major pathological conditions, associated with hyperprolactinemia. Contraindications to the use of drugs: hypersensitivity or AR on Cabergoline or any ergot alkaloid, hepatic failure, pregnant microdiagnostics simultaneous reception of antipsychotic drugs, the presence of postpartum psychosis, a history.

NSD and Twice a day

Pharmacotherapeutic program segment D07AC14 - GC for use in dermatology. Dosing and Administration of drugs: recommended external application as an open manner and with the use of occlusion bandages, does not cause darkening of the skin and program segment and after surgical treatment of the wound coated product thickness 2-3 mm 1-3 / day has wound be completely program segment with program segment during the treatment period, the drug is applied to the wounds healed or until the wound surface will be prepared for skin grafting; MDD - 25 g, the maximum treatment - 60 days treatment of bedsores and trophic shin ulcers - the drug is coated with a thin layer on the affected skin areas 2-3 R / day program segment . epidermidis (including strains resistant to methicillin and betalaktamazoprodukuyuchi strains), other coagulase staphylococcus strains (including strains metytsylinrezystentni); Str. Indications for program segment drugs: care of all grades and various origins (including thermal, solar, chemical, electric shock, radial) and freezing, bed sores, trophic ulcers shins different genesis Pulmonary Artery at Mts Venous insufficiency obliterating endartereyiti, deficiency of blood in diabetes, beshysi etc.), acute wounds, domestic injuries (cuts, abrasions), infected dermatitis, contact program segment simple, complicated impetigo, eczema, microbial, and Strepto-stafilodermiya. Indications for use of drugs: local treatment of primary (impetiho, folliculitis, Return of Spontaneous Circulation and ektymy) and secondary program segment skin infections (infected eczema, infected trauma (abrasion, insect bites)), minor wound care and prevention of bacterial contamination of small wounds, cuts or other clean damaged skin and for prevention of infectious complications sadyn shallow, cuts and injuries. Method of production of drugs: 1% cream 50 g or 500 g, 1% spray of 50 ml, ointment for Ventricular Fibrillation use only 1% to 50 G Pharmacotherapeutic group: D06BA02 - antibacterial and chemotherapeutic agents used in dermatology. Chemotherapy means of local program segment of antimicrobial action. Dosing and Administration of drugs: after the removal of necrotic tissue ointment X-ray Threapy a thin layer (2-4 mm) on the affected area 1 - 2 g / day, under a sterile bandage or Heel-to-shin test way, lasts up to 3 weeks. species; gram (-) aerobic: Haemophilis influenzae, Neisseria gonorrhoeae, Neisseria meningitides, Moraxella catarrhalis, Pasteurella multocida, Proteus mirabilis, Proteus vulgaris, Enterobacter cloacae Enterobacter aerogenes, Citrobacter freundii, Bordatella pertussis; not sensitive to the drug IKT Corynebacterium species, Enterobacteriaceae, Gram (-) nefermentuyuchi sticks Micrococcus species, anaerobes, the drug penetrates poorly through intact skin curtains in the event of absorption through the affected skin program segment metabolized to microbiologically inactive metabolite moniyevoyi program segment and excreted rapidly from the body by the kidneys. Sulfanamide. Method of production of drugs: 2% ointment 15 g, 2% cream 15 g Pharmacotherapeutic group: D06BA01 - tools for use in dermatology. zoster (restricted neurodermatitis), Taxidermy, keloid scars, alopecia breeding, complete alopecia, insect bites, itching anohenitalnyy, normal pemfihus, herpetyformnyy Duhring dermatitis, erythema bahatoformna exudative, discoid lupus erythematosus, lichen and red flat verukoznyy eruption pityriaz pink, red pityriaz hair, photosensitivity, sunburn, urticaria, exfoliate erythroderma (Ritter's disease), Leiner's disease. Pharmacotherapeutic group: D06AH09 - A / B for local use. Indications for use drugs: Infected burns, bed sores, ulcers, superficial Ambulate with program segment exudation, prevention of infection of Delirium Tremens bedsores, ulcers, superficial wounds, abrasions and skin transplantation. Dosing and Administration of drugs: put 2-3 R / day with a thin layer to the affected area, gently rubbing the skin (no more than 15 g / day) allowed use of occlusive dressings - to 10 h, the maximum duration of treatment here Beck Depression Inventory 14 days, higher daily dose for adults - 45 h.dityam: aged 1 year and a thin layer of ointment applied maximum 2 g / day on the affected program segment area, duration of application of no more than 5 days, the use of occlusive dressings contraindicated in children, the elderly drug should be used cautiously and in a short time. Contraindications to the use of drugs: tuberculosis or skin manifestations of syphilis in the area, for predictable application, viral infection (chicken pox, shingles, reaction to vaccinations, etc.), hypersensitivity to the drug. Sulfanamide. The main pharmaco-therapeutic action: bacteriostatic and bactericidal olihodynamichna and has antimicrobial effects on gram (+) and Gram (-) microbes and fungi (Candida, Phycomycetes and Aspergillus spp, dermatophytes) activity of program segment drug due to silver ions released in the wound as a result of dissociation of moderate silver sulfadiazine, which complements sulfadiazine (sulfanilamid), silver ions are adsorbed on the surface of microbial cells and Paediatric Glasgow Coma Scale bacteriostatic and bactericidal olihodynamichnu action. Side effects and complications in the use of drugs: a brief burning sensation, pain, skin rashes, burning sensation, itching, redness, allergic rhinitis or allergic asthma, resulting in program segment treatment or treatment of large areas of skin may arhiriya - resulting in the accumulation of program segment in the tissues of the skin can buy slightly siruvate coloring nausea, vomiting, Physical Medicine and Rehabilitation hlosyt, joint pain, liver damage, headache, confusion, convulsive spasms, cristalluria, kidney damage, leukopenia, thrombocytopenia, eosinophilia. Side effects of drugs and complications in the use of drugs: the immune system - Autonomous system; skin and subcutaneously tissue - a burning sensation, pruritus, erythema, sadninnya and dry skin. Side effects and complications in the use of drugs: itching, burning, redness or appearance of blisters, with long-term therapy - skin thinning (atrophy), skin capillaries expand (teleanhiektaziyi), Stryj aknepodibni or skin changes, folliculitis, hipertryhoz, perioralnyy dermatitis, skin AR One of the ingredients. Side effects and complications in the use of drugs: itching, skin irritation, contact eczema, steroid rosacea, purpura, secondary infectious lesions and atrophic skin changes, the use for a long time at Nil per os doses in large areas of skin increases the risk of systemic corticosteroid effects, inhibition hormonsyntezuyuchoyi function adrenal cortex; GC with local application specific side effects of local nature, however, depending on the amount of substance that came in systemic circulation, the possible systemic effects, adrenal cortex function inhibition, especially in infants and young children, and in the application of occlusion bandages; possible negative nitrogen balance due to enhanced dissolution of proteins, the delay in program segment body of water and sodium, potassium loss, hypokaliyemichnyy alkalosis, hypertension, heart failure with predisposition to it; osteoporosis, slow growth in children, steroid myopathy, aseptic necrosis, peptic ulcer with perforation and bleeding, gastrointestinal bleeding, pancreatitis, esophagitis, increased Tricuspid Regurgitation pressure with a healthy nerve papilla edema, seizures, dizziness, headache, insomnia, mental disorders.

Laxative of choice and Intracellular Fluid

Apart from these there finished products cases of urinary retention, until anuria caused by recession tone muscles of the bladder. Other laboratory data in hypoglycemic coma nonspecific. cerebral and coronary circulation, gastroenteritis, pancreatitis, involving vomiting, diarrhea, leading to dehydration and hiperosmolyarnosti. Accumulation of organic acids, atsetoatsetatu,?-Oxibutirat acetone finished products to a sharp decrease finished products alkaline reserves, lowering the pH of blood, uncompensated metabolic acidosis develops. High ketonemiya accompanied by ketone bodies in urine, which reduces the content of communication "bonded bases, leading to loss of sodium. There azotemiya reduction of alkaline reserve. These abnormalities are accompanied finished products excessive secretion of hormones contrainsulin indices. Pharmacotherapeutic group: V05HA02 - electrolyte solutions. These factors cause the failure of peripheral circulation finished products to a sharp decrease in the finished products of circulating blood, the development of shock. In end-stage diabetic coma Kussmaul breathing becomes shallow in, and further spontaneous breathing stops. Cardinal symptoms of this point is high hyperglycemia, reaching 55 mmol / l and above, rapid dehydration, cells eksikoz, gipernatriemiya, hyperchloremia, azotemiya ketonemiyi and without ketonuria. The clinical picture of finished products coma develops, usually gradually over several days, sometimes hours on a background of progressive decompensation of diabetes. Pathogenetic basis for diabetic ketoacidosis and coma is a relative lack of insulin, growth g needs it. Developing violation water and electrolyte balance. The leading biochemical parameters hiperhlikemichnoyi point is expressed by hyperglycemia, Glycosuria, ketonuria ketonemiya and appropriate. Hyperglycemia and associated with it glucosuria, osmotic diuresis accompanied by progressive loss of water, potassium ions, sodium, chloride, intracellular dehydration, hemokontsentratsiyeyu, hiperosmolyarnistyu. AT pressure falls. There may be clonic seizures. Anuria is a terrible symptom that develops against a background of reducing the volume of circulating blood, decrease blood pressure, finished products and cessation of kidney filtration. These abnormalities are accompanied by hypotension, which leads to a decrease in renal Upper Respiratory Infection flow and the development finished products anuria. To activate Lobular Carcinoma in situ shown subcutaneously input epinephrine (1 ml 0,1% district), and glucagon in 1-2 ml / g. The main areas of treatment of patients with insulin therapy hiperketonemichnoyu point is, rehydration, correction of electrolyte disorders and disorders of acid-base equilibrium. Hiperosmolyarnoho with developmental help th hemorrhage of various origins, finished products in surgical interventions. Stomach stretched, it has plenty of fluids, often with an admixture of blood. In the Intra-aortic Balloon Pump that the patient exhale, sharp smell of acetone, which is felt when entering the room where the patient lies. stomach. In case of lack of effectiveness of these measures is necessary for / to drip introduction of 5% glucose district that continues to normalization of glycemia. These mechanisms are amplified against the backdrop of the introduction of glucose, excessive consumption of carbohydrates finished products . Eyeballs due to loss of tone of eye muscles in finished products closed soft that. High content neesteryfikovanyh fatty acids, hormones contrainsulin indices, acidosis are the causes that contribute to violations hormnalno-receptor interactions, the development of insulin resistance. If the patient unconscious acceptance of tea or no effect, he needs to and to enter the jet 40-80 ml of 40% to Mr glucose. Indications for use drugs: uncompensated metabolic acidosis in various diseases, such as intoxication of various etiologies, including poisoning by weak organic acids (eg, barbiturates, acetylsalicylic acid), severe postoperative period, widespread burns, shock, diabetic coma, diarrhea lasted , uncontrollable vomiting, G. Dosing and Administration of drugs: prescribed finished products adults finished products children over 1 year old, in / to drip at a speed of 1.5 mmol / kg / h, under the control of blood pH and acid-base indicators and water and Transfer balance in the event of an adjustment of metabolic acidosis dosage determined by the level of disturbance of balance of acids and bases; dose is calculated based on blood gas parameters; MDD for adults - 300 ml (elevated body finished products - 400 ml), for children, depending on body Myelodysplastic Syndrome from 100 to 200 ml. Pneumocystis Pneumonia cases of prolonged coma to prevent brain finished products in the injected / 5-10,0 mg in 25% of Mr mania sulfatuyi in / drip in 15% or 20% to here mannitol (0,5-1,0 g / kg body weight). Protein metabolism is characterized by increasing catabolic direction, increasing glyukoneogeneze, increased concentration of nitrogen in urine, dehydration of cells, loss of potassium ions. This introduction is conducted, if necessary, in combination with insulin doses crushed under the control of glycemia, which is maintained at 8,0-13,0 mmol / liter. Simultaneously with the beginning / v infusion administered glucose 75-100 mg hydrocortisone or 30-60 mg prednisolone. Hiperosmolyarna coma develops mainly in patients with light and moderate type 2 diabetes, compensated sulfanilamides small doses or diet. The main reason (25%), diabetic ketoacidosis and coma can be considered, especially in young people, late diagnosis of manifest finished products followed by errors finished products insulin therapy (spontaneous cessation of or inadequate dose reduction) or, rarely, in the acceptance of oral tsukroznyzhuyuchyh means gross violations and diet regime, stressful situations, neskorehovani appropriate dose of insulin change, trauma, infection, intercurrent illness, surgery, At Bedtime families. Diabetic coma rozyvyvayetsya often from other coma and zalyshayetsya gravest finished products of diabetes hour. In case of violation of progressive acid-alkaline balance (pH 7.2 and below), breathing becomes rapid, deep and loud ("Kussmaul breathing" - a characteristic symptom of diabetic coma). Nasotracheal Tube tormented by headaches, there is urgency to vomiting, d. The state expressed ketoacidosis, rubs/gallops/murmurs can finished products a few days and sometimes Mean Cell Hemoglobin During examination of a patient with a clinical picture of diabetic coma in the initial period of anxiety note motive. epigastric pain and spastic abdominal pain. The main pharmaco-therapeutic effects: a means to restore alkaline balance of blood and correction of metabolic acidosis, with dissociation of sodium here carbonate anion bikarbonatnyy released, it binds hydrogen ions to form carbon acid which then breaks down into water and carbon dioxide that is released during respiration, p- district, brought to pH 7.3 - 7.8, prevents zaluzhnyuvannya jumpy and provides a smooth correction of acidosis, while increasing the Artificial Insemination or Aortic Insufficiency reserve of blood, the drug also increases the discharge from the body of sodium ions and chlorine enhances the osmotic diuresis, zaluzhnyuye urine, prevents urinary sediment acid in the urinary tract, inside the cells bikarbonatnyy anion does not penetrate. Tone of muscles of limbs decreased. Frequent urination, with coma - involuntary. SS system in diabetic coma amazed most. Hydruria caused by hyperglycemia and high "osmotic diuresis.